Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype : COPD-Asthma

Chest

Volumn 145, Issue 2, 2014, Pages 297-304

  Menezes, Ana Maria B ^a   De Oca, Maria Montes ^b   Pérez Padilla, Rogelio ^c   Nadeau, Gilbert ^d   Wehrmeister, Fernando César ^a   Lopez Varela, Maria Victorina ^e   Muiño, Adriana ^f   Jardim, José Roberto B ^g   Valdivia, Gonzalo ^h   Tálamo, Carlos ^b  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d GLAXOSMITHKLINE   (United Kingdom)

^e DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^f Centro Hospitalario Pereira Rossell   (Uruguay)

^g FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^h PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SALBUTAMOL;

ABSENTEEISM; ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE ASTHMA OVERLAP; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SOUTH AND CENTRAL AMERICA; SPIROMETRY; WHEEZING;

ADULT; AGED; ASTHMA; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHENOTYPE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 84893689291     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0622     Document Type: Article

References (30)

1. Buist AS , McBurnie MA , Vollmer WM , et al ; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007 ; 370 ( 9589 ): 741-750.
2. Caballero A , Torres-Duque CA , Jaramillo C , et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008 ; 133 ( 2 ): 343-349.
3. Menezes AM , Perez-Padilla R , Jardim JR , et al ; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet. 2005 ; 366 ( 9500 ): 1875-1881.
4. Zhong N, Wang C, Yao W , et al. Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care Med. 2007 ; 176 ( 8 ): 753-760.
5. Bateman ED , Hurd SS , Barnes PJ , et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008 ; 31 ( 1 ): 143-178.
6. Han MK , Agusti A , Calverley PM , et al. Chronic obstructive pulmonary disease phenotypes: The future of COPD. Am J Respir Crit Care Med. 2010 ; 182 ( 5 ): 598-604.
7. Hardin M , Silverman EK , Barr RG , et al ; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011 ; 12 : 127.
8. Tálamo C , de Oca MM , Halbert R , et al ; PLATINO team. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007 ; 131 ( 1 ): 60-67.
9. Marsh SE , Travers J , Weatherall M , et al. Proportional classifications of COPD phenotypes. Thorax. 2008 ; 63 ( 9 ): 761-767.
10. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995 ; 152 ( 3 ): 1107-1136.
11. Menezes AM , Victora CG , Perez-Padilla R ; PLATINO Team. The Platino project: Methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004 ; 4 : 15.
12. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD website. http://www.goldcopd.org/uploads/users/files/GOLDReport- April112011.pdf. Updated 2010. Accessed April 22, 2013.
13. Pérez-Padilla R , Valdivia G , Muiño A , et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over [in Spanish]. Arch Bronconeumol. 2006; 42( 7): 317-325.
14. Variations in the prevalence of respiratory symptoms, selfreported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1996 ; 9 ( 4 ): 687-695.
15. Chinn S , Burney P , Jarvis D , Luczynska C. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1997; 10( 11): 2495-2501.
16. Janson C , Chinn S , Jarvis D , Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997 ; 10 ( 8 ): 1795-1802.
17. Manfreda J , Becklake MR , Sears MR , et al. Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ. 2001 ; 164 ( 7 ): 995-1001.
18. Arif AA , Delclos GL , Lee ES , Tortolero SR , Whitehead LW. Prevalence and risk factors of asthma and wheezing among US adults: An analysis of the NHANES III data. Eur Respir J. 2003 ; 21 ( 5 ): 827-833.
19. Sembajwe G , Cifuentes M , Tak SW , Kriebel D , Gore R , Punnett L. National income, self-reported wheezing and asthma diagnosis from the World Health Survey. Eur Respir J. 2010 ; 35 ( 2 ): 279-286.
20. Beeh KM , Kornmann O , Beier J , Ksoll M , Buhl R. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med. 2004 ; 98 ( 7 ): 591-597.
21. Soriano JB , Davis KJ , Coleman B , Visick G , Mannino D , Pride NB. The proportional Venn diagram of obstructive lung disease: Two approximations from the United States and the United Kingdom. Chest. 2003 ; 124 ( 2 ): 474-481.
22. Izquierdo-Alonso JL, Rodriguez-Gonzálezmoro JM, de Lucas-Ramos P , et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med. 2013 ; 107 ( 5 ): 724-731.
23. Miravitlles M , Soriano JB , Ancochea J , et al. Characteri sation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013; 107( 7): 1053-1060.
24. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): Prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS ONE. 2013 ; 8 ( 5 ): E62985.
25. Mannino DM , Gagnon RC , Petty TL , Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160( 11): 1683-1689.
26. Kauppi P , Kupiainen H , Lindqvist A , et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011 ; 48 ( 3 ): 279-285.
27. Andersson F , Borg S , Jansson SA , et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med. 2002 ; 96 ( 9 ): 700-708.
28. Hilleman DE , Dewan N , Malesker M , Friedman M. Pharmaco economic evaluation of COPD. Chest. 2000 ; 118 ( 5 ): 1278-1285.
29. Miravitlles M , Murio C , Guerrero T , Gisbert R ; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002 ; 121 ( 5 ): 1449-1455.
30. Rutten-van Mölken MP , Postma MJ, Joore MA, Van Genugten ML , Leidl R , Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med. 1999 ; 93 ( 11 ): 779-787.